Europa Biosite's Stake Sold to EQT Healthcare Growth
Deal News | Jul 03, 2025 | White & Case LLP
Global law firm White & Case LLP has guided Adelis on the transaction involving the sale of its majority stake in Europa Biosite to EQT Healthcare Growth. Europa Biosite, under the stewardship of Adelis since 2021, developed a robust buy-and-build strategy, resulting in the acquisition of five companies over four years and establishing a significant European and North American commercial presence. This transaction marks the continuation of Adelis's strategy of expansion and value creation, having managed approximately 4.5 billion in capital since its inception and executing numerous investments and acquisitions. The deal showcases the thriving partnership and synergetic capabilities of Adelis and EQT Healthcare Growth, both leaders in the private equity industry.
Sectors
- Private Equity
- Healthcare
- Life Sciences
Geography
- Europe – The transaction involves European entities and mentions Europa Biosite's operations across multiple European countries.
- North America – Europa Biosite's operations also extend to North America, indicating its broad geographical presence.
Industry
- Private Equity – The article discusses Adelis, a private equity firm managing a significant portfolio and involved in the sale of its stake in a company.
- Healthcare – EQT Healthcare Growth's acquisition of Europa Biosite aligns with its focus on health-related investments, particularly in life sciences.
- Life Sciences – Europa Biosite operates as a distributor in the life sciences industry, providing essential research reagents.
Financials
- Approximately 4.5 billion – This describes the capital under management by Adelis, the private equity firm involved in the transaction.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| White & Case LLP | Legal Advisor | Company | A global law firm that advised Adelis on the transaction of selling Europa Biosite to EQT Healthcare Growth. |
| Adelis | Seller/Vendor | Company | A private equity firm that sold its majority stake in Europa Biosite. |
| Europa Biosite | Target Company | Company | A distributor of life science research reagents, which was partially owned by Adelis. |
| EQT Healthcare Growth | Buyer | Company | The acquiring entity that purchased the majority stake in Europa Biosite. |